ANXA10 and neoplasm: The neural network classifier showed a good performance and outperformed an immunohistochemistry-based signature comprising ANXA1 (annexin A1) and ANXA10 (annexin A10) in recognizing iCCA precursor lesions and pCCA, both showing high similarity with the tumor [100].